Update on the role of p75NTR in neurological disorders: A novel therapeutic target

Biomedicine and Pharmacotherapy

Volumn 76, Issue , 2015, Pages 17-23

  Shu, Ya Hai ^a,b   Lu, Xiu Min ^b   Wei, Jing Xiang ^b   Xiao, Lan ^b   Wang, Yong Tang ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHONGQING UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Neurological disorder; Neurotrophic factor; P75 neurotrophin receptor; Therapeutic target

Indexed keywords

NEUROTROPHIN RECEPTOR P75; TAU PROTEIN; NERVE GROWTH FACTOR RECEPTOR;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CELL CYCLE; CELL DEATH; COGNITION; HUMAN; MAJOR DEPRESSION; MEMORY; NERVE CELL; NERVE CELL PLASTICITY; NERVE DEGENERATION; NEUROLOGIC DISEASE; NONHUMAN; PARKINSON DISEASE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SCHIZOPHRENIA; ANIMAL; APOPTOSIS; CELL CYCLE CHECKPOINT; CELL MOTION; CELL SURVIVAL; MENTAL DISEASE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL MOVEMENT; CELL SURVIVAL; HUMANS; MENTAL DISORDERS; NERVOUS SYSTEM DISEASES; RECEPTOR, NERVE GROWTH FACTOR;

EID: 84949214803     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2015.10.010     Document Type: Review

References (67)

1. Balaratnasingam S., Janca A. Brain derived neurotrophic factor: a novel neurotrophin involved in psychiatric and neurological disorders. Pharmacol. Ther. 2012, 134(1):116-124.
2. Frey B.N., Andreazza A.C., Houenou J., Jamain S., Goldstein B.I., Frye M.A., et al. Biomarkers in bipolar disorder: a positional paper from the International Society for Bipolar Disorders Biomarkers Task Force. Aust. N. Z. J. Psychiatry 2013, 47(4):321-332.
3. Blöchl A., Blöchl R. A cell-biological model of p75NTR signaling. J. Neurochem. 2007, 102(2):289-305.
4. He X.L., Garcia K.C. Structure of nerve growth factor complexed with the shared neurotrophin receptorp75. Science 2004, 304(5672):870-875.
5. Guo J., Wang J., Liang C., Yan J., Wang Y., Liu G., et al. proNGF inhibits proliferation and Oligodendro genesis of postnatal Hippocampal neural stem/progenitor cells through p75NTR invitro. Stem Cell Res. 2013, 11(2):874-887.
6. Arnett M.G., Ryals J.M., Wright D.E. ProNGF, sortilin, and p75NTR: potential mediatorsf injury-induced apoptosis in the mouse dorsal root ganglion. Brain Res. 2007, 1183:32-42.
7. waf1. Cell Signal. 2010, 22(12):1864-1873.
8. Jiang Y., Chen G., Zheng Y., Lu L., Wu C., Zhang Y., et al. TLR4 signaling induces functional nerve growth factor receptor p75NTR on mouse dendritic cells via p38MAPK and NF-κB pathways. Mol. Immunol. 2008, 45(6):1557-1566.
9. Zeng F., Lu J.J., Zhou X.F., Wang Y.J. Roles of p75NTR in the pathogenesis of Alzheimer's disease: a novel therapeutic target. Biochem. Pharmacol. 2011, 82(10):1500-1509.
10. Mattson M.P., Partin J., Begley J.G. Amyloid beta-peptide induces apoptosis-related events in synapses and dendrites. Brain Res. 1998, 807(1-2):167-176.
11. Chakravarthy B., Gaudet C., Menard M., Atkinson T., Brown L., Laferla F.M., et al. Amyloid-beta peptides stimulate the expression of the p75NTR neurotrophin receptor in SHSY5Y human neuroblastoma cells and AD transgenic mice. Alzheimers Dis. 2010, 19(3):915-925.
12. Wang Y.J., Wang X., Lu J.J., Li Q.X., Gao C.Y., Liu X.H., et al. p75NTR regulates Abeta deposition by increasing Abeta production but inhibiting Aβ aggregation with its extracellular domain. J. Neurosci. 2011, 31(6):2292-2304.
13. Ginsberg S.D., Che S., Wuu J., Counts S.E., Mufson E.J. Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease. Neurochemistry 2006, 97(2):475-487.
14. Bengoechea T.G., Chen Z., O'Leary D., Masliah E., Lee K.F. p75 reduces beta-amyloid-induced sympathetic innervation deficits in an Alzheimer's disease mouse model. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(19):7870-7875.
15. Amadoro G., Corsetti V., Ciotti M.T., Florenzano F., Capsoni S., Amato G., et al. Endogenous Aβ causes cell death via early tau hyperphosphorylation. Neurobiol. Aging 2011, 32(6):969-990.
16. Hu X.Y., Zhang H.Y., Qin S., Xu H., Swaab D.F., Zhou J.N. Increased p75NTR expression in hippocampal neurons containing hyperphosphorylated tau in Alzheimer patients. Exp. Neurol. 2002, 178(1):104-111.
17. Pedraza C.E., Podlesniy P., Vidal N., Arevalo J.C., Lee R., Hempstead B., et al. Pro-NGF isolated from the human brain affected by Alzheimer's disease induces neuronal apoptosis mediated by p75NTR. Am. J. Pathol. 2005, 166(2):533-543.
18. Clewes O., Fahey M.S., Tyler S.J., Watson J.J., Seok H., Catania C., et al. Human ProNGF: biological effects and binding profiles at TrkA, P75NTR and sortilin. J. Neurochem. 2008, 107(4):1124-1135.
19. Peng S., Wuu J., Mufson E.J., Fahnestock M. Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease. Neuropathol. Exp. Neurol. 2004, 63(6):641-649.
20. Perälä J., Suvisaari J., Saarni S.I., Kuoppasalmi K., Isometsä E., Pirkola S., et al. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch. Gen. Psychiatry 2007, 64(1):19-28.
21. McGrath J.J., Féron F.P., Burne T.H., Mackay-Sim A., Eyles D.W. The neurodevelopmental hypothesis of schizophrenia: a review of recent developments. Ann. Med. 2003, 35(2):86-93.
22. Shoval G., Weizman A. The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia. Eur. Neuropsychopharmacol. 2005, 15(3):319-329.
23. Young K.M., Merson T.D., Sotthibundhu A., Coulson E.J., Bartlett P.F. p75 Neurotrophin receptor expression defines a population of BDNF-responsive neurogenic precursorcells. J. Neurosci. 2007, 27(19):5146-5155.
24. Neves-Pereira M., Cheung J.K., Pasdar A., Zhang F., Breen G., Yates P., et al. BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol. Psychiatry 2005, 10(2):208-212.
25. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003, 112(2):257-269.
26. Rosa A., Cuesta M.J., Fatjó-Vilas M., Peralta V., Zarzuela A., Fañanás L. The Val66Met polymorphism of brain-derived neurotrophic factor is associated with risk for psychosis: evidence from a family-based association study. Am. J. Med. Genet. Neuropsychiatr. Genet. 2006, 141B(2):135-138.
27. Olff M., Langeland W., Gersons B.P. he psychobiology of PTSD: coping with trauma. Psychoneuroendocrinology 2005, 30(10):974-982.
28. Teng H.K., Teng K.K., Lee R., Wright S., Tevar S., Almeida R.D., et al. ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin. J. Neurosci. 2005, 25(22):5455-5463.
29. Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O'Donovan M.C., Sullivan P.F., et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460(7256):748-752.
30. Dalman C., Allebeck P., Gunnell D., Harrison G., Kristensson K., Lewis G., et al. Infections in the CNS during childhood and the risk of subsequent psychotic illness: a cohort study of more than one million Swedish subjects. Am. J. Psychiatry 2008, 165(1):59-65.
31. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., Monteggia L.M. Neurobiology of depression. Neuron 2002, 34(1):13-25.
32. Hidaka B.H. Depression as a disease of modernity: explanations for increasing prevalence. J. Affect. Disord. 2012, 140(3):205-214.
33. Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006, 3(11):e442.
34. Du M.Y., Wu Q.Z., Yue Q., Li J., Liao Y., Kuang W.H., et al. Voxelwise meta-analysis of gray Matter reduction in major depressive disorder. Prog. Neuropsychol. Pharmacol. Biol. Psychiatry 2012, 36(1):11-16.
35. Dwivedi Y., Rizavi H.S., Zhang H., Mondal A.C., Roberts R.C., Conley R.R., et al. Neurotrophin receptor activation and expression in human postmortem brain: effect of suicide. Biol .Psychiatry 2009, 65(4):319-328.
36. Zhou L., Xiong J., Lim Y., Ruan Y., Huang C., Zhu Y., et al. Upregulation of blood proBDNF and its receptors in major depression. J. Affect. Disord. 2013, 150(3):776-784.
37. Daniel P.B., Lux W., Samson A.L., Schleuning W.D., Niego B., Weiss T.W., et al. Two conserved regions within the tissue-type plasminogen activator gene promoter mediate regulation by brain-derived neurotrophic factor. FEBS J. 2007, 274(9):2411-2423.
38. McEwen B.S. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol. Rev. 2007, 87(3):873-904.
39. Kessler R.C., Sonnega A., Bromet E., Hughes M., Nelson C.B. Posttraumatic stress disorder in the National Comorbidity Survey. Arch. Gen. Psychiatry 1995, 52:1048-1060.
40. Tolin D.F., Foa E.B. Sex differences in trauma and posttraumatic stress disorder: a quantitative review of 25 years of research. Psychol. Bull. 2006, 132(6):959-992.
41. Sartor C.E., McCutcheon V.V., Pommer N.E., Nelson E.C., Grant J.D., Duncan A.E., et al. Common genetic and environmental contributions to post-traumatic stress disorder and alcohol dependence in young women. Psychol. Med. 2011, 41:1497-1505. 7.
42. Cloitre M., Stolbach B.C., Herman J.L., van, der K., olk B., Pynoos R., Wang J., et al. A developmental approach to complex PTSD: childhood and adult cumulative trauma as predictors of symptom complexity. J. Trauma Stress 2009, 22(5):399-408.
43. Blanco C., Xu Y., Brady K., Pérez-Fuentes G., Okuda M., Wang S. Comorbidity of posttraumatic stress disorder with alcohol dependence among US adults: results from national epidemiological survey on alcohol and related conditions. Drug Alcohol Depend. 2013, 132(3):630-638.
44. Maher M.J., Rego S.A., Asnis G.M. Sleep disturbancesin patients with post-traumatic stress disorder: epidemiology, impact and approaches to management. CNS Drugs 2006, 20(7):567-590.
45. Chen D.Y., Bambah-Mukku D., Pollonini G., Alberini C.M. Glucocorticoid receptors recruit the CaMKIIα-BDNF-CREB pathways to mediate memory consolidation. Nat. Neurosci. 2012, 15(12):1707-1714.
46. Rosen D.R. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 364(6435):362.
47. Manfredi G., Xu Z. Mitochondrial dysfunction and its role in motor neuron degeneration in ALS. Mitochondrion 2005, 5(2):77-87.
48. Ekestern E. Neurotrophic factors and amyotrophic lateral sclerosis. Neurodegener Dis. 2004, 1(2-3):88-100.
49. Dewil M., Lambrechts D., Sciot R., Shaw P.J., Ince P.G., Robberecht W., et al. Vascular endothelial growth factor counteracts the loss of phospho-Akt preceding motor neurone degeneration in amyotrophic lateral sclerosis. Neuropathol. Appl. Neurobiol. 2007, 33(5):499-509.
50. Kriz J.G., owing G., Julien J.P. Efficient three-drug cocktail for disease induced by mutant superoxide dismutase. Ann. Neurol. 2003, 53(4):429-436.
51. Copray J.C., Jaarsma D., Küst B.M., Bruggeman R.W., Mantingh I., Brouwer N., et al. Expression of the low affinity neurotrophin receptor p75 in spinal motoneurons in a transgenic mouse model for amyotrophic lateral sclerosis. Neuroscience 2003, 116(3):685-694.
52. Lowry K.S., Murray S.S., McLean C.A., Talman P., Mathers S., Lopes E.C., et al. A potential role for the p75 low-affinity neurotrophin receptor in spinal motor neuron degeneration in murine and human amyotrophic lateral sclerosis. Amyotroph. Lateral Scler 2001, 2(3):127-134.
53. Worth P.F. When the going gets tough: how to select patients with Parkinson's disease for advanced therapies. Pract. Neurol. 2013, 13(3):140-152.
54. Smith L.M., Schiess M.C., Coffey M.P., Klaver A.C., Loeffler D.A. α-Synuclein and anti-α-synuclein antibodies in Parkinson's disease, atypical Parkinson syndromes, REM sleep behavior disorder, and healthy controls. PLoS One 2012, 7(12):e52285.
55. Dawbarn D., Allen S.J. Neurotrophins and neurodegeneration. Neuropathol. Appl. Neurobiol. 2003, 29(3):211-230.
56. Volosin M., Song W., Almeida R.D., Kaplan D.R., Hempstead B.L., Friedman W.J. Interaction of survival and death signaling in basal forebrain neurons: roles of neurotrophins and proneurotrophins. J. Neurosci. 2006, 26(29):7756-7766.
57. Domeniconi M., Hempstead B.L., Chao M.V. Pro-NGF secreted by astrocytes promotes motor neuron cell death. Mol. Cell. Neurosci. 2007, 34(2):271-279.
58. Stahl K., Mylonakou M.N., Skare Ø., Amiry-Moghaddam M., Torp R. Cytoprotective effects of growth factors: BDNF more potent than GDNF in an organotypic culture model of Parkinson's disease. Brain Res. 2011, 1378:105-118.
59. Hashimoto Y., Kaneko Y., Tsukamoto E., Frankowski H., Kouyama K., Kita Y., et al. Molecular characterization of neurohybrid cell death induced by Alzheimer's amyloid-beta peptides via p75NTR/PLAIDD. Neurochemistry 2004, 90(3):549-558.
60. Costantini C., Della-Bianca V., Formaggio E., Chiamulera C., Montresor A., Rossi F. The expression of p75 neurotrophin receptor protects against the neurotoxicity of soluble oligomers of beta-amyloid. Exp. Cell Res. 2005, 311(3):126-134.
61. Hoogenraad C.C., Bradke F. Control of neuronal polarity and plasticity-a renaissance for microtubules?. Trends Cell Biol. 2009, 19(12):669-676.
62. Chen Q., Zhou Z., Zhang L., Wang Y., Zhang Y.W., Zhong M., et al. Tau protein is involved in morphological plasticity in hippocampal neurons in response to BDNF. Neurochem. Int. 2012, 60(3):233-242.
63. Worth P.F. When the going gets tough: how to select patients with Parkinson's disease for advanced therapies. Pract. Neurol. 2013, 13(3):140-152.
64. Morillo S.M., Escoll P., de la Hera A., Frade J.M. Somatic tetraploidy in specific chick retinal ganglion cells induced by nerve growth factor. Proc. Natl. Acad. Sci. U. S. A. 2010, 107(1):109-114.
65. Cragnolini A.B., Huang Y., Gokina P., Friedman W.J. Nerve growth factor attenuates proliferation of astrocytes via the p75 neurotrophin receptor. Glia 2009, 57(13):1386-1392.
66. Daniel P.B., Lux W., Samson A.L., Schleuning W.D., Niego B., Weiss T.W., et al. Two conserved regions within the tissue-type plasminogen activator gene promoter mediate regulation by brain-derived neurotrophic factor. FEBS J. 2007, 274(9):2411-2423.
67. Numakawa T., Adachi N., Richards M., Chiba S., Kunugi H. Brain-derived neurotrophic factor and glucocorticoids: reciprocal influence on the central nervous system. Neuroscience 2013, 239:157-172.